✦ LIBER ✦

Leukemia-associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemia

✍ Scribed by Jochen Greiner; Michael Schmitt

Book ID: 114794384
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 258 KB
Volume: 80
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2008.01053.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New insights into antigen specific immun

New insights into antigen specific immunotherapy for chronic myeloid leukemia

✍ Yangqiu Li, Chen Lin, Christian A Schmidt 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 190 KB

mRNA expression of leukemia-associated a

mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies

✍ Jochen Greiner; Mark Ringhoffer; Masanori Taniguchi; Li Li; Anita Schmitt; Hiros 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 1 views

## Abstract Specific immunotherapies for patients with acute myeloid leukemia (AML) using leukemia‐associated antigens (LAA) as target structures might be a therapeutic option to enhance the graft‐__vs__.‐leukemia effect observed after allogeneic stem cell transplantation or to prolong a complete r

Hematopoietic stem cells and progenitors

Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy

✍ Yong, A S M; Keyvanfar, K; Eniafe, R; Savani, B N; Rezvani, K; Sloand, E M; Gold 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 575 KB

Receptor for hyaluronan acid–mediated mo

Receptor for hyaluronan acid–mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

✍ Jochen Greiner; Mark Ringhoffer; Masanori Taniguchi; Anita Schmitt; Dieter Kirch 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 336 KB

CD52 as a molecular target for immunothe

CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression

✍ Saito, Y; Nakahata, S; Yamakawa, N; Kaneda, K; Ichihara, E; Suekane, A; Morishit 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 710 KB

HLA-DP as specific target for cellular i

HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia

✍ Rutten, C E; van Luxemburg-Heijs, S A P; Griffioen, M; Marijt, E W A; Jedema, I; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 179 KB